Vendor review
PeptiSlim reviews
PeptiSlim reviews from 74 independent lab tests (Tirzepatide, Retatrutide and GHK-Cu): grade A, purity and fill accuracy. Is PeptiSlim legit? See what its vials showed.
What the lab tests show
74 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 5, 2026 | Tirzepatide | 99.9 % | 32.1 mg of 30 mg (7 %) | Pass | View |
| Aug 28, 2026 | Tirzepatide | 99.8 % | 34.3 mg of 30 mg (14 %) | Pass | View |
| Aug 28, 2026 | Tirzepatide | 99.9 % | 65.2 mg of 60 mg (9 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 99.9 % | 9.26 mg of 10 mg (-7 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 99.9 % | 9.94 mg of 10 mg (-1 %) | Pass | View |
| Jul 14, 2026 | Tesamorelin | 98.2 % | 4.62 mg of 5 mg (-8 %) | Pass | View |
| Jun 26, 2026 | Tirzepatide | 99.9 % | 48.8 mg of 50 mg (-2 %) | Pass | View |
| Jun 26, 2026 | Tirzepatide | 99.9 % | 58.3 mg of 60 mg (-3 %) | Pass | View |
| Jun 26, 2026 | Tirzepatide | 99.9 % | 37.8 mg of 40 mg (-6 %) | Pass | View |
| Jun 26, 2026 | Tirzepatide | 99.9 % | 29.1 mg of 30 mg (-3 %) | Pass | View |
| Jun 26, 2026 | Tirzepatide | 99.8 % | 22.1 mg of 20 mg (11 %) | Pass | View |
| Jun 23, 2026 | Tirzepatide | 99.8 % | 9.57 mg of 10 mg (-4 %) | Pass | View |
| Jun 22, 2026 | Tirzepatide | 99.9 % | 9.53 mg of 10 mg (-5 %) | Pass | View |
| Jun 17, 2026 | Tirzepatide | 99.8 % | 17.7 mg of 20 mg (-12 %) | Pass | View |
| Jun 17, 2026 | Tirzepatide | 99.7 % | 26.3 mg of 20 mg (32 %) | Pass | View |
| Jun 17, 2026 | Tirzepatide | 99.8 % | 35.6 mg of 30 mg (19 %) | Pass | View |
| Jun 17, 2026 | Retatrutide | 99.8 % | 9.8 mg of 10 mg (-2 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.9 % | 60.6 mg of 60 mg (1 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.9 % | 19.6 mg of 20 mg (-2 %) | Pass | View |
| Apr 23, 2026 | GHK-Cu | 99.8 % | 103.3 mg of 99.99 mg (3 %) | Pass | View |
| Mar 25, 2026 | Tirzepatide | 99.7 % | 5.3 mg of 5 mg (6 %) | Pass | View |
| Mar 25, 2026 | Semaglutide | 99.9 % | 12.1 mg of 10 mg (21 %) | Pass | View |
| Mar 16, 2026 | Tirzepatide | 99.9 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Mar 10, 2026 | GHK-Cu | 99.9 % | 81.1 mg of 100 mg (-19 %) | Pass | View |
| Mar 7, 2026 | Retatrutide | 99.9 % | 67.8 mg of 60 mg (13 %) | Pass | View |
| Mar 7, 2026 | Cagrilintide | 99.9 % | 11.7 mg of 10 mg (17 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 11 mg of 10 mg (10 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 99.85 % | 30.2 mg of 30 mg (1 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 99.15 % | 15.7 mg of 15 mg (5 %) | Pass | View |
| Mar 3, 2026 | Retatrutide | 99.9 % | 31.5 mg of 30 mg (5 %) | Pass | View |
| Feb 26, 2026 | Tirzepatide | 99.9 % | 54.2 mg of 50 mg (8 %) | Pass | View |
| Feb 26, 2026 | Retatrutide | 99.9 % | 19.3 mg of 20 mg (-3 %) | Pass | View |
| Feb 22, 2026 | GHK-Cu | 99.9 % | 54.8 mg of 50 mg (10 %) | Pass | View |
| Feb 20, 2026 | Tirzepatide | 99.88 % | 14 mg of 10 mg (40 %) | Pass | View |
| Feb 20, 2026 | Retatrutide | 99.76 % | 4.46 mg of 5 mg (-11 %) | Pass | View |
| Feb 19, 2026 | GHK-Cu | 99.9 % | 43.4 mg of 50 mg (-13 %) | Pass | View |
| Feb 18, 2026 | Retatrutide | 99.02 % | 57.9 mg of 60 mg (-4 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 99.63 % | 63.8 mg of 60 mg (6 %) | Pass | View |
| Feb 18, 2026 | Tesamorelin | 99.31 % | 11.4 mg of 10 mg (14 %) | Pass | View |
| Feb 18, 2026 | Retatrutide | 99.9 % | 28.3 mg of 30 mg (-6 %) | Pass | View |
| Feb 10, 2026 | Tesamorelin | 99.6 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Feb 10, 2026 | Retatrutide | 99.9 % | 62 mg of 60 mg (3 %) | Pass | View |
| Feb 4, 2026 | Semaglutide | 99.8 % | 32.8 mg of 30 mg (9 %) | Pass | View |
| Feb 4, 2026 | GHK-Cu | 98.9 % | 120.8 mg of 100 mg (21 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.7 % | 21 mg of 20 mg (5 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.8 % | 71.7 mg of 60 mg (20 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.7 % | 36.4 mg of 30 mg (21 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.7 % | 66.5 mg of 60 mg (11 %) | Pass | View |
| Jan 26, 2026 | GHK-Cu | 99.9 % | 109 mg of 100 mg (9 %) | Pass | View |
| Jan 19, 2026 | Retatrutide | 99.95 % | 27.6 mg of 30 mg (-8 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.8 % | 21.9 mg of 20 mg (10 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.9 % | 34 mg of 30 mg (13 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.8 % | 51.7 mg of 60 mg (-14 %) | Pass | View |
| Jan 15, 2026 | Semaglutide | 98.19 % | 8.09 mg of 20 mg (-60 %) | Pass | View |
| Jan 9, 2026 | Tirzepatide | 99.95 % | 63.7 mg of 60 mg (6 %) | Pass | View |
| Jan 6, 2026 | Semaglutide | 99.7 % | 5.45 mg of 5 mg (9 %) | Pass | View |
| Jan 6, 2026 | Cagrilintide | 98.71 % | 5.45 mg of 5 mg (9 %) | Pass | View |
| Dec 29, 2025 | Tirzepatide | 99.95 % | 30 mg of 30 mg (0 %) | Pass | View |
| Dec 16, 2025 | Retatrutide | 99.6 % | 9.4 mg of 10 mg (-6 %) | Pass | View |
| Dec 16, 2025 | Retatrutide | 99.6 % | 10.2 mg of 10 mg (2 %) | Pass | View |
What PeptiSlim sells
No current listings on record.
About PeptiSlim
Finnrick has tested 74 samples from PeptiSlim across 6 products.